Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Docosanoids [FA04]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA04020516 (4S,7R,10R)-d5-8-NeuroF[8S,11S] (4S,7R,E)-4,7-dihydroxy-7-((2S,4R,5S)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid FA 22:5;O4 C22H34O6 394.235540
LMFA04020517 (4S,7R,10S)-d5-8-NeuroF[8R,11R] (4S,7R,E)-4,7-dihydroxy-7-((2R,4S,5R)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid FA 22:5;O4 C22H34O6 394.235540
LMFA04020518 (4S,7R,10S)-d5-8-NeuroF[8R,11S] (4S,7R,E)-4,7-dihydroxy-7-((2R,4S,5S)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid FA 22:5;O4 C22H34O6 394.235540
LMFA04020519 (4S,7R,10S)-d5-8-NeuroF[8S,11R] (4S,7R,E)-4,7-dihydroxy-7-((2S,4S,5R)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid FA 22:5;O4 C22H34O6 394.235540
LMFA04020520 (4S,7R,10S)-d5-8-NeuroF[8S,11S] (4S,7R,E)-4,7-dihydroxy-7-((2S,4S,5S)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid FA 22:5;O4 C22H34O6 394.235540
LMFA04020521 (4S,7S,10R)-d5-8-NeuroF[8R,11R] (4S,7S,E)-4,7-dihydroxy-7-((2R,4R,5R)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid FA 22:5;O4 C22H34O6 394.235540
LMFA04020522 (4S,7S,10R)-d5-8-NeuroF[8R,11S] (4S,7S,E)-4,7-dihydroxy-7-((2R,4R,5S)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid FA 22:5;O4 C22H34O6 394.235540
LMFA04020523 (4S,7S,10R)-d5-8-NeuroF[8S,11R] (4S,7S,E)-4,7-dihydroxy-7-((2S,4R,5R)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid FA 22:5;O4 C22H34O6 394.235540
LMFA04020524 (4S,7S,10R)-d5-8-NeuroF[8S,11S] (4S,7S,E)-4,7-dihydroxy-7-((2S,4R,5S)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid FA 22:5;O4 C22H34O6 394.235540
LMFA04020525 (4S,7S,10S)-d5-8-NeuroF[8R,11R] (4S,7S,E)-4,7-dihydroxy-7-((2R,4S,5R)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid FA 22:5;O4 C22H34O6 394.235540
LMFA04020526 (4S,7S,10S)-d5-8-NeuroF[8R,11S] (4S,7S,E)-4,7-dihydroxy-7-((2R,4S,5S)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid FA 22:5;O4 C22H34O6 394.235540
LMFA04020527 (4S,7S,10S)-d5-8-NeuroF[8S,11R] (4S,7S,E)-4,7-dihydroxy-7-((2S,4S,5R)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid FA 22:5;O4 C22H34O6 394.235540
LMFA04020528 (4S,7S,10S)-d5-8-NeuroF[8S,11S] (4S,7S,E)-4,7-dihydroxy-7-((2S,4S,5S)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid FA 22:5;O4 C22H34O6 394.235540
LMFA04010441 7-epi-14-A4-NeuroP (Z)-6-((1S,2R)-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010442 ent-14-epi-14-A4-NeuroP (Z)-6-((1S,2S)-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010443 17-epi-17-A4-NeuroP (4Z,7Z)-9-((1R,2R)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010444 ent-10-epi-17-A4-NeuroP (4Z,7Z)-9-((1R,2S)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010445 10,17-diepi-17-A4-NeuroP (4Z,7Z)-9-((1S,2R)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010446 ent-17-A4-NeuroP (4Z,7Z)-9-((1S,2S)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010447 17-A4-NeuroP (4Z,7Z)-9-((1R,2R)-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010448 ent-10,17-diepi-17-A4-NeuroP (4Z,7Z)-9-((1R,2S)-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010449 10-epi-17-A4-NeuroP (4Z,7Z)-9-((1S,2R)-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010450 ent-17-epi-17-A4-NeuroP (4Z,7Z)-9-((1S,2S)-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010451 20-epi-20-A4-NeuroP (4Z,7Z,10Z)-12-((1R,2R)-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010452 ent-13-epi-20-A4-NeuroP (4Z,7Z,10Z)-12-((1R,2S)-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010453 13,20-diepi-20-A4-NeuroP (4Z,7Z,10Z)-12-((1S,2R)-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010454 ent-20-A4-NeuroP (4Z,7Z,10Z)-12-((1S,2S)-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010455 20-A4-NeuroP (4Z,7Z,10Z)-12-((1R,2R)-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010456 ent-13,20-diepi-20-A4-NeuroP (4Z,7Z,10Z)-12-((1R,2S)-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010457 13-epi-20-A4-NeuroP (4Z,7Z,10Z)-12-((1S,2R)-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010458 ent-20-epi-20-A4-NeuroP (4Z,7Z,10Z)-12-((1S,2S)-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010459 4-epi-4-J4-NeuroP (R,E)-4-hydroxy-6-((1S,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010460 ent-7-epi-4-J4-NeuroP (R,E)-4-hydroxy-6-((1S,5R)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010461 4,7-diepi-4-J4-NeuroP (R,E)-4-hydroxy-6-((1R,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010462 ent-4-J4-NeuroP (R,E)-4-hydroxy-6-((1R,5R)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010463 4-J4-NeuroP (S,E)-4-hydroxy-6-((1S,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010464 ent-4,7-diepi-4-J4-NeuroP (S,E)-4-hydroxy-6-((1S,5R)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010465 7-epi-4-J4-NeuroP (S,E)-4-hydroxy-6-((1R,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010466 ent-4-epi-4-J4-NeuroP (S,E)-4-hydroxy-6-((1R,5R)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010467 7-epi-7-J4-NeuroP (R,4Z,8E)-7-hydroxy-9-((1S,5S)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010468 ent-10-epi-7-J4-NeuroP (R,4Z,8E)-7-hydroxy-9-((1S,5R)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010469 7,10-diepi-7-J4-NeuroP (R,4Z,8E)-7-hydroxy-9-((1R,5S)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010328 4-epi-11-E4t-NeuroP 3-((1R,2R,3R)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010329 4-epi-11-E4c-NeuroP 3-((1S,2S,3R)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010330 11-E4t-NeuroP 3-((1S,2R,3R)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010331 ent-13-E4t-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010332 ent-16-epi-13-E4c-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010333 ent-16-epi-13-E4t-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010334 ent-13-E4c-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010335 13-epi-13-E4c-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2S,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:6;O3 C22H32O5 376.224975